Spinnaker Trust ownership in BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,44 € ↑0,88 (1,88%)

2026-06-03
AKTIENPREIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Spinnaker Trust
Latest Disclosed Ownership	14,848 shares
Latest Disclosed Value	$ 900,531

On April 23, 2026 - Spinnaker Trust filed a 13F-HR form disclosing ownership of 14,848 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $778,332 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 14,848 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $704,315 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-23	2026-03-31	13F	Bristol Myers Squibb	Equities	110122108	14,848	0	0.00	901	12.50	0.0438
2026-02-10	2025-12-31	13F	Bristol Myers Squibb	Equities	110122108	14,848	-258	-1.71	801	17.47	0.0429
2025-11-05	2025-09-30	13F	Bristol Myers Squibb	Equities	110122108	15,106	-212	-1.38	681	-3.95	0.0378
2025-08-04	2025-06-30	13F	Bristol Myers Squibb	Equities	110122108	15,318	0	0.00	709	-24.09	0.0426
2025-04-25	2025-03-31	13F	Bristol Myers Squibb	Equities	110122108	15,318	-715	-4.46	934	3.09	0.0610
2025-01-30	2024-12-31	13F	Bristol Myers Squibb	Equities	110122108	16,033	1,113	7.46	907	17.51	0.0572
2024-10-31	2024-09-30	13F	Bristol Myers Squibb	Equities	110122108	14,920	-310	-2.04	772	21.99	0.0476
2024-07-31	2024-06-30	13F	Bristol Myers Squibb	Equities	110122108	15,230	194	1.29	633	-22.45	0.0405
2024-05-06	2024-03-31	13F	Bristol Myers Squibb	Equities	110122108	15,036	-3,705	-19.77	815	-15.19	0.0526
2024-02-02	2023-12-31	13F	Bristol Myers Squibb	Equities	110122108	18,741	-23,191	-55.31	962	-60.50	0.0654
2023-11-08	2023-09-30	13F	Bristol Myers Squibb	Equities	110122108	41,932	1,385	3.42	2,434	-6.13	0.1832
2023-08-01	2023-06-30	13F	Bristol Myers Squibb	Equities	110122108	40,547	7,906	24.22	2,593	14.59	0.1883
2023-04-13	2023-03-31	13F	Bristol Myers Squibb	Equities	110122108	32,641	-198	-0.60	2,262	113,000.00	0.1714
2023-02-02	2022-12-31	13F	Bristol Myers Squibb	Equities	110122108	32,839	370	1.14	2	-99.91	0.1841
2022-10-28	2022-09-30	13F	Bristol Myers Squibb	Equities	110122108	32,469	82	0.25	2,308	-7.46	0.1914
2022-07-25	2022-06-30	13F	Bristol Myers Squibb	Equities	110122108	32,387	4,775	17.29	2,494	23.65	0.1924
2022-05-02	2022-03-31	13F	Bristol Myers Squibb	Equities	110122108	27,612	250	0.91	2,017	18.23	0.1360
2022-01-31	2021-12-31	13F	Bristol Myers Squibb	Equities	110122108	27,362	-1,671	-5.76	1,706	-0.70	0.1093
2021-11-02	2021-09-30	13F	Bristol Myers Squibb	Equities	110122108	29,033	392	1.37	1,718	-10.19	0.1195
2021-08-09	2021-06-30	13F	Bristol Myers Squibb	Equities	110122108	28,641	-30,559	-51.62	1,913	-48.81	0.1332
2021-04-30	2021-03-31	13F	Bristol Myers Squibb	Equities	110122108	59,200	6,377	12.07	3,737	14.07	0.2804
2021-01-26	2020-12-31	13F	Bristol Myers Squibb	Equities	110122108	52,823	-1,830	-3.35	3,276	-0.55	0.2612
2020-10-27	2020-09-30	13F	Bristol Myers Squibb	Equities	110122108	54,653	1,086	2.03	3,294	4.60	0.2920
2020-07-21	2020-06-30	13F	Bristol Myers Squibb	Equities	110122108	53,567	231	0.43	3,149	5.96	0.2985
2020-05-05	2020-03-31	13F	Bristol Myers Squibb	Equities	110122108	53,336	-4,102	-7.14	2,972	-19.37	0.3268
2020-02-05	2019-12-31	13F	Bristol Myers Squibb	Equities	110122108	57,438	1,060	1.88	3,686	28.97	0.3367
2019-11-12	2019-09-30	13F	Bristol Myers Squibb	Equities	110122108	56,378	192	0.34	2,858	12.21	0.2820
2019-07-11	2019-06-30	13F	Bristol Myers Squibb	Equities	110122108	56,186	3,694	7.04	2,547	1.76	0.2558
2019-04-29	2019-03-31	13F	Bristol Myers Squibb	Equities	110122108	52,492	964	1.87	2,503	-6.50	0.2516
2019-02-04	2018-12-31	13F	Bristol Myers Squibb	Equities	110122108	51,528	4,362	9.25	2,677	-8.54	0.3040
2018-10-23	2018-09-30	13F	Bristol Myers Squibb	Equities	110122108	47,166	2,167	4.82	2,927	17.55	0.2892
2018-08-02	2018-06-30	13F	Bristol Myers Squibb	Equities	110122108	44,999	4,365	10.74	2,490	-3.08	0.2653
2018-05-10	2018-03-31	13F	Bristol Myers Squibb	Equities	110122108	40,634	75	0.18	2,569	3.42	0.2795
2018-02-09	2017-12-31	13F	Bristol Myers Squibb	Equities	110122108	40,559	-510	-1.24	2,484	-5.08	0.2883
2017-10-26	2017-09-30	13F	Bristol Myers Squibb	Equities	110122108	41,069	-13,324	-24.50	2,617	-13.66	0.3270
2017-07-27	2017-06-30	13F	Bristol Myers Squibb	Com	110122108	54,393	598	1.11	3,031	3.62	0.3787
2017-05-10	2017-03-31	13F	Bristol Myers Squibb	Com	110122108	53,795	-174	-0.32	2,925	-7.26	0.3800
2017-02-15	2016-12-31	13F	Bristol Myers Squibb	Com	110122108	53,969	46,279	601.81	3,154	542.36	0.4242
2016-11-03	2016-09-30	13F	Bristol Myers Squibb	Com	110122108	7,690	-23,732	-75.53	491	-78.75	0.0690
2016-08-01	2016-06-30	13F	Bristol Myers Squibb	Com	110122108	31,422	23,732	308.61	2,311	370.67	0.3185
2016-05-05	2016-03-31	13F	Bristol Myers Squibb	Com	110122108	7,690	-16	-0.21	491	-7.36	0.0690
2016-01-29	2015-12-31	13F	Bristol Myers Squibb	Com	110122108	7,706	-253	-3.18	530	12.53	0.0757
2015-11-06	2015-09-30	13F	Bristol Myers Squibb	Com	110122108	7,959	200	2.58	471	-8.72	0.0721
2015-08-05	2015-06-30	13F	Bristol Myers Squibb	Com	110122108	7,759	-601	-7.19	516	-4.27	0.0770
2015-04-17	2015-03-31	13F	Bristol Myers Squibb	Com	110122108	8,360	-680	-7.52	539	0.94	0.0778
2015-01-22	2014-12-31	13F	Bristol Myers Squibb	Com	110122108	9,040	-537	-5.61	534	8.98	0.0793
2014-11-03	2014-09-30	13F	Bristol Myers Squibb	Com	110122108	9,577	0	0.00	490	5.38	0.0791
2014-07-28	2014-06-30	13F	Bristol Myers Squibb	Com	110122108	9,577	-1,000	-9.45	465	-15.30	0.0762
2014-04-23	2014-03-31	13F	Bristol Myers Squibb	Com	110122108	10,577	233	2.25	549	-0.18	0.0903
2014-01-24	2013-12-31	13F	Bristol Myers Squibb	Com	110122108	10,344	-1,055	-9.26	550	4.17	0.0916
2013-10-28	2013-09-30	13F	Bristol Myers Squibb	Com	110122108	11,399	-300	-2.56	528	0.96	0.0957
2013-08-08	2013-06-30	13F	Bristol Myers Squibb	Com	110122108	11,699	11,699		523		0.0984

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.